Matches in Nanopublications for { ?s ?p "[Although the PI3K-AKT pathway is known to be dysregulated in retinoblastoma, the low frequency of oncogenic mutations in the AKT1, PIK3CA, and PTEN genes, suggests a different activating mechanism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- NP628235.RAQLkuAWLe2UjU3dhMHZ_yfhMyJm8UlJWD-G69XGEkbsw130_assertion description "[Although the PI3K-AKT pathway is known to be dysregulated in retinoblastoma, the low frequency of oncogenic mutations in the AKT1, PIK3CA, and PTEN genes, suggests a different activating mechanism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP628235.RAQLkuAWLe2UjU3dhMHZ_yfhMyJm8UlJWD-G69XGEkbsw130_provenance.
- NP723185.RAS3rz1fLsMRTjURA4NPq_ut12FBZp-4F7bdvjzA40xdo130_assertion description "[Although the PI3K-AKT pathway is known to be dysregulated in retinoblastoma, the low frequency of oncogenic mutations in the AKT1, PIK3CA, and PTEN genes, suggests a different activating mechanism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP723185.RAS3rz1fLsMRTjURA4NPq_ut12FBZp-4F7bdvjzA40xdo130_provenance.
- assertion description "[Although the PI3K-AKT pathway is known to be dysregulated in retinoblastoma, the low frequency of oncogenic mutations in the AKT1, PIK3CA, and PTEN genes, suggests a different activating mechanism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Although the PI3K-AKT pathway is known to be dysregulated in retinoblastoma, the low frequency of oncogenic mutations in the AKT1, PIK3CA, and PTEN genes, suggests a different activating mechanism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP414171.RAVA0etpEwqibHTAdCfoIaPn0q1lLA6EJKaj__JuthsPY130_assertion description "[Although the PI3K-AKT pathway is known to be dysregulated in retinoblastoma, the low frequency of oncogenic mutations in the AKT1, PIK3CA, and PTEN genes, suggests a different activating mechanism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP414171.RAVA0etpEwqibHTAdCfoIaPn0q1lLA6EJKaj__JuthsPY130_provenance.
- NP87816.RAdXOq1t38J600IavrWoOBoEUMYFhQyL_UNsHipVdLowI130_assertion description "[Although the PI3K-AKT pathway is known to be dysregulated in retinoblastoma, the low frequency of oncogenic mutations in the AKT1, PIK3CA, and PTEN genes, suggests a different activating mechanism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP87816.RAdXOq1t38J600IavrWoOBoEUMYFhQyL_UNsHipVdLowI130_provenance.
- NP232240.RAWcdbFPvlg2YD-4NfBWhPZvv4AFk4q-uXegdONcPkZEc130_assertion description "[Although the PI3K-AKT pathway is known to be dysregulated in retinoblastoma, the low frequency of oncogenic mutations in the AKT1, PIK3CA, and PTEN genes, suggests a different activating mechanism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP232240.RAWcdbFPvlg2YD-4NfBWhPZvv4AFk4q-uXegdONcPkZEc130_provenance.
- assertion description "[Although the PI3K-AKT pathway is known to be dysregulated in retinoblastoma, the low frequency of oncogenic mutations in the AKT1, PIK3CA, and PTEN genes, suggests a different activating mechanism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP107075.RApSx8vQGgrjiRD8C3ngd-28168JMgOgUVviWHUBB_ka0130_assertion description "[Although the PI3K-AKT pathway is known to be dysregulated in retinoblastoma, the low frequency of oncogenic mutations in the AKT1, PIK3CA, and PTEN genes, suggests a different activating mechanism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP107075.RApSx8vQGgrjiRD8C3ngd-28168JMgOgUVviWHUBB_ka0130_provenance.
- NP736985.RAok4DatRoouMtg9FymjJtZ1Nz-0A6Qo03K1fs3PM3OF0130_assertion description "[Although the PI3K-AKT pathway is known to be dysregulated in retinoblastoma, the low frequency of oncogenic mutations in the AKT1, PIK3CA, and PTEN genes, suggests a different activating mechanism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP736985.RAok4DatRoouMtg9FymjJtZ1Nz-0A6Qo03K1fs3PM3OF0130_provenance.
- NP146691.RAI831eO3zY1Uj7oW_62csLqlmda62KGdRi5JLFiQdROI130_assertion description "[Although the PI3K-AKT pathway is known to be dysregulated in retinoblastoma, the low frequency of oncogenic mutations in the AKT1, PIK3CA, and PTEN genes, suggests a different activating mechanism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP146691.RAI831eO3zY1Uj7oW_62csLqlmda62KGdRi5JLFiQdROI130_provenance.
- NP146693.RApOIvEJAbUpuCCxv_G95txsxudBcP0lqahRZrczkBMT0130_assertion description "[Although the PI3K-AKT pathway is known to be dysregulated in retinoblastoma, the low frequency of oncogenic mutations in the AKT1, PIK3CA, and PTEN genes, suggests a different activating mechanism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP146693.RApOIvEJAbUpuCCxv_G95txsxudBcP0lqahRZrczkBMT0130_provenance.